LUNCHEON 11:30 a.m.; LECTURE 12:00 p.m.
Under Flatleys leadership, Illumina has been named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to Forbes 25 Fastest-Growing Tech Companies (2007, 2009 and 2010) and the Fortune 100 Fastest-Growing Companies (2010) lists. In 2006, he oversaw the Companys expansion into the whole genome sequencing area with the acquisition of Solexa, and more recently, the expansion into diagnostics and consumer sequencing.
Previously, Flatley served as president and chief executive officer of Molecular Dynamics, later acquired by Amersham Pharmacia Biotech and now a part of GE Healthcare. As a co-founder and member of the board of directors for Molecular Dynamics, he led the company to its initial public offering in 1993. While there, he also helped Molecular Dynamics develop and launch more than 15 major instrumentation systems, including the first capillary-based DNA sequencer.
Flatley received a B.A. in economics from Claremont McKenna College and a B.S. and M.S. (summa cum laude) in industrial engineering from Stanford University. Currently, he is a trustee of the Keck Graduate Institute of Applied Life Sciences, which is a member of The Claremont Colleges.
This luncheon is co-sponsored by the Presidents Leaders Forum and the Robert Day School of Economics and Finances Distinguished Speaker Series.